BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 16964553)

  • 1. Polymorphisms in the repeat long regions of oncogenic and attenuated pathotypes of Marek's disease virus 1.
    Spatz SJ; Silva RF
    Virus Genes; 2007 Aug; 35(1):41-53. PubMed ID: 16964553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Mutational analysis of Meq, RLORF4, RLORF12 and 132bpr genes of epidemic Marek's disease virus strains highly passaged on chicken embryo fibroblast].
    Liu AL; Liu CJ; Zhang YP; Li JM; Shi WS; Yan FH; Zhang F; Cheng ZW
    Bing Du Xue Bao; 2009 Sep; 25(5):368-75. PubMed ID: 19954114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequence determination of a mildly virulent strain (CU-2) of Gallid herpesvirus type 2 using 454 pyrosequencing.
    Spatz SJ; Rue CA
    Virus Genes; 2008 Jun; 36(3):479-89. PubMed ID: 18351449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clustering of mutations within the inverted repeat regions of a serially passaged attenuated gallid herpesvirus type 2 strain.
    Spatz SJ; Rue C; Schumacher D; Osterrieder N
    Virus Genes; 2008 Aug; 37(1):69-80. PubMed ID: 18516669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequence determination of variable regions within the genomes of gallid herpesvirus-2 pathotypes.
    Spatz SJ; Silva RF
    Arch Virol; 2007; 152(9):1665-78. PubMed ID: 17557133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative full-length sequence analysis of Marek's disease virus vaccine strain 814.
    Zhang F; Liu CJ; Zhang YP; Li ZJ; Liu AL; Yan FH; Cong F; Cheng Y
    Arch Virol; 2012 Jan; 157(1):177-83. PubMed ID: 21984218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accumulation of attenuating mutations in varying proportions within a high passage very virulent plus strain of Gallid herpesvirus type 2.
    Spatz SJ
    Virus Res; 2010 May; 149(2):135-42. PubMed ID: 20109506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of deletions within the Bam HI-L fragment of attenuated Marek's disease virus on vIL-8 expression and the newly identified transcript of open reading frame LORF4.
    Jarosinski KW; O'Connell PH; Schat KA
    Virus Genes; 2003 May; 26(3):255-69. PubMed ID: 12876454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative analysis of oncogenic genes revealed unique evolutionary features of field Marek's disease virus prevalent in recent years in China.
    Tian M; Zhao Y; Lin Y; Zou N; Liu C; Liu P; Cao S; Wen X; Huang Y
    Virol J; 2011 Mar; 8():121. PubMed ID: 21406076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative analysis of Marek's disease virus (MDV) glycoprotein-, lytic antigen pp38- and transformation antigen Meq-encoding genes: association of meq mutations with MDVs of high virulence.
    Shamblin CE; Greene N; Arumugaswami V; Dienglewicz RL; Parcells MS
    Vet Microbiol; 2004 Sep; 102(3-4):147-67. PubMed ID: 15327791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative full-length sequence analysis of oncogenic and vaccine (Rispens) strains of Marek's disease virus.
    Spatz SJ; Petherbridge L; Zhao Y; Nair V
    J Gen Virol; 2007 Apr; 88(Pt 4):1080-1096. PubMed ID: 17374751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterizing the molecular basis of attenuation of Marek's disease virus via in vitro serial passage identifies de novo mutations in the helicase-primase subunit gene UL5 and other candidates associated with reduced virulence.
    Hildebrandt E; Dunn JR; Perumbakkam S; Niikura M; Cheng HH
    J Virol; 2014 Jun; 88(11):6232-42. PubMed ID: 24648463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative genomic sequence analysis of the Marek's disease vaccine strain SB-1.
    Spatz SJ; Schat KA
    Virus Genes; 2011 Jun; 42(3):331-8. PubMed ID: 21336949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of Marek's disease virus in different chicken populations in Iraq and indicative virulence based on sequence variation in the ecoRI-q (meq) gene.
    Wajid SJ; Katz ME; Renz KG; Walkden-Brown SW
    Avian Dis; 2013 Jun; 57(2 Suppl):562-8. PubMed ID: 23901776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular characterization and phylogenetic analysis of oncogenes from virulent serotype-1 Marek's disease virus in India.
    Prathibha Y; Sreedevi B; Kumar NV; Srilatha CH
    Acta Virol; 2018; 62(3):277-286. PubMed ID: 30160143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Newly detected mutations in the Meq oncogene and molecular pathotyping of very virulent Marek's disease herpesvirus in Tunisia.
    Lachheb J; Mastour H; Nsiri J; Kaboudi K; Choura I; Ammouna F; Amara A; Ghram A
    Arch Virol; 2020 Nov; 165(11):2589-2597. PubMed ID: 32876794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequence analysis of meq oncogene among Polish strains of Marek's disease.
    Woźniakowski G; Samorek-Salamonowicz E; Kozdruń W
    Pol J Vet Sci; 2010; 13(2):263-7. PubMed ID: 20731180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural co-infection with two virulent wild strains of Marek's disease virus in a commercial layer flock.
    Yu Z; Zhang Y; Lan X; Wang Y; Zhang F; Gao Y; Li K; Gao L; Pan Q; Qi X; Cui H; Zhou L; Sun G; Wang X; Liu C
    Vet Microbiol; 2020 Jan; 240():108501. PubMed ID: 31902513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection and molecular characterization of a highly oncogenic Marek's disease virus from vaccinated hens in Turkey.
    Abayli H; Karabulut B; Ozbek R; Ongor H; Timurkaan N; Tonbak S
    Acta Virol; 2021; 65(2):212-220. PubMed ID: 34130472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamic equilibrium of Marek's disease genomes during in vitro serial passage.
    Spatz SJ; Volkening JD; Gimeno IM; Heidari M; Witter RL
    Virus Genes; 2012 Dec; 45(3):526-36. PubMed ID: 22923089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.